4. Less FDA enforcement
Science magazine reports that FDA enforcement has slumped under the Trump administration — with the president apparently making good on his promise to deregulate industries. Warning letters are reportedly off by a third, and medical device warnings are off by two-thirds.
FDA has also faced some operational challenges this year, from the U.S. government shutdown to Commissioner Dr. Scott Gottlieb’s resignation.